Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigen.
Huang K, Schatka I, Rogasch JMM, Lindquist RL, De Santis M, Erber B, Radojewski P, Brenner W, Amthauer H. Huang K, et al. Among authors: radojewski p. Ann Nucl Med. 2021 Mar;35(3):314-320. doi: 10.1007/s12149-020-01567-3. Epub 2020 Dec 22. Ann Nucl Med. 2021. PMID: 33351172 Free PMC article.
Towards tailored radiopeptide therapy.
Radojewski P, Dumont R, Marincek N, Brunner P, Mäcke HR, Müller-Brand J, Briel M, Walter MA. Radojewski P, et al. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1231-7. doi: 10.1007/s00259-015-3030-9. Epub 2015 Mar 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 25792454 Free article.
Upregulation of Key Molecules for Targeted Imaging and Therapy.
Taelman VF, Radojewski P, Marincek N, Ben-Shlomo A, Grotzky A, Olariu CI, Perren A, Stettler C, Krause T, Meier LP, Cescato R, Walter MA. Taelman VF, et al. Among authors: radojewski p. J Nucl Med. 2016 Nov;57(11):1805-1810. doi: 10.2967/jnumed.115.165092. Epub 2016 Jun 30. J Nucl Med. 2016. PMID: 27363833 Free article.
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.
Brunner P, Jörg AC, Glatz K, Bubendorf L, Radojewski P, Umlauft M, Marincek N, Spanjol PM, Krause T, Dumont RA, Maecke HR, Müller-Brand J, Briel M, Schmitt A, Perren A, Walter MA. Brunner P, et al. Among authors: radojewski p. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):468-475. doi: 10.1007/s00259-016-3486-2. Epub 2016 Aug 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 27539020 Free article. Clinical Trial.
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues.
Umlauft M, Radojewski P, Spanjol PM, Dumont R, Marincek N, Kollar A, Brunner P, Beyersmann J, Müller-Brand J, Maecke HR, Laimer M, Walter MA. Umlauft M, et al. Among authors: radojewski p. J Nucl Med. 2017 Sep;58(9):1532. doi: 10.2967/jnumed.117.190660. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280219 Free article. No abstract available.
46 results